Happy 2022 and everything goes well

News 2021.12.317318

Related News

China's First! Neuboron's Domestic Boron Drug Approved for IND Clinical Trials

2024.01.09
Device Installation Starts at China's First Accelerator-based BNCT Center

2020.08.14
Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

2023.08.15
BNCT in the Spotlight at the 1st China Conference on Cancer Particle Therapy Engineering Technology

2019.11.29